462 related articles for article (PubMed ID: 12688308)
21. CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells.
Buhmann R; Nolte A; Westhaus D; Emmerich B; Hallek M
Blood; 1999 Mar; 93(6):1992-2002. PubMed ID: 10068672
[TBL] [Abstract][Full Text] [Related]
22. Induction of type 2 activity in adult human CD8(+) T cells by repeated stimulation and IL-4.
Stanciu LA; Roberts K; Lau LC; Coyle AJ; Johnston SL
Int Immunol; 2001 Mar; 13(3):341-8. PubMed ID: 11222503
[TBL] [Abstract][Full Text] [Related]
23. Effect of tetravalent bispecific CD19xCD3 recombinant antibody construct and CD28 costimulation on lysis of malignant B cells from patients with chronic lymphocytic leukemia by autologous T cells.
Reusch U; Le Gall F; Hensel M; Moldenhauer G; Ho AD; Little M; Kipriyanov SM
Int J Cancer; 2004 Nov; 112(3):509-18. PubMed ID: 15382079
[TBL] [Abstract][Full Text] [Related]
24. CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells.
Martens AWJ; Janssen SR; Derks IAM; Adams Iii HC; Izhak L; van Kampen R; Tonino SH; Eldering E; van der Windt GJW; Kater AP
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581054
[TBL] [Abstract][Full Text] [Related]
25. Generation of B-cell chronic lymphocytic leukemia (B-CLL)-reactive T-cell lines and clones from HLA class I-matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapy.
Hoogendoorn M; Wolbers JO; Smit WM; Schaafsma MR; Barge RM; Willemze R; Falkenburg JH
Leukemia; 2004 Jul; 18(7):1278-87. PubMed ID: 15116118
[TBL] [Abstract][Full Text] [Related]
26. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
de Waal Malefyt R; Yssel H; de Vries JE
J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
[TBL] [Abstract][Full Text] [Related]
27. Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22.
Ghia P; Strola G; Granziero L; Geuna M; Guida G; Sallusto F; Ruffing N; Montagna L; Piccoli P; Chilosi M; Caligaris-Cappio F
Eur J Immunol; 2002 May; 32(5):1403-13. PubMed ID: 11981828
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of CD154/IL4 proliferation by the T follicular helper (Tfh) cytokine, IL21 and increased numbers of circulating cells resembling Tfh cells in chronic lymphocytic leukaemia.
Ahearne MJ; Willimott S; Piñon L; Kennedy DB; Miall F; Dyer MJ; Wagner SD
Br J Haematol; 2013 Aug; 162(3):360-70. PubMed ID: 23710828
[TBL] [Abstract][Full Text] [Related]
29. Ibrutinib for improved chimeric antigen receptor T-cell production for chronic lymphocytic leukemia patients.
Fan F; Yoo HJ; Stock S; Wang L; Liu Y; Schubert ML; Wang S; Neuber B; Hückelhoven-Krauss A; Gern U; Schmitt A; Müller-Tidow C; Dreger P; Schmitt M; Sellner L
Int J Cancer; 2021 Jan; 148(2):419-428. PubMed ID: 32683672
[TBL] [Abstract][Full Text] [Related]
30. CD28- T lymphocytes. Antigenic and functional properties.
Azuma M; Phillips JH; Lanier LL
J Immunol; 1993 Feb; 150(4):1147-59. PubMed ID: 8381831
[TBL] [Abstract][Full Text] [Related]
31. High endothelial venules and cell adhesion molecules in B-cell chronic lymphocytic leukaemia and related low grade B-cell lymphoma/leukaemia: II. Expression of cell adhesion molecules in lymph nodes biopsies.
Csanaky G
Histol Histopathol; 1994 Jul; 9(3):577-82. PubMed ID: 7526911
[TBL] [Abstract][Full Text] [Related]
32. A novel method using blinatumomab for efficient, clinical-grade expansion of polyclonal T cells for adoptive immunotherapy.
Golay J; D'Amico A; Borleri G; Bonzi M; Valgardsdottir R; Alzani R; Cribioli S; Albanese C; Pesenti E; Finazzi MC; Quaresmini G; Nagorsen D; Introna M; Rambaldi A
J Immunol; 2014 Nov; 193(9):4739-47. PubMed ID: 25267972
[TBL] [Abstract][Full Text] [Related]
33. T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers.
Palma M; Gentilcore G; Heimersson K; Mozaffari F; Näsman-Glaser B; Young E; Rosenquist R; Hansson L; Österborg A; Mellstedt H
Haematologica; 2017 Mar; 102(3):562-572. PubMed ID: 27927767
[TBL] [Abstract][Full Text] [Related]
34. Intracellular IFN-gamma expression by CD3+/CD8+ cell subset in B-CLL patients correlates with stage of the disease.
Podhorecka M; Dmoszynska A; Rolinski J
Eur J Haematol; 2004 Jul; 73(1):29-35. PubMed ID: 15182335
[TBL] [Abstract][Full Text] [Related]
35. CD23 is recognized as tumor-associated antigen (TAA) in B-CLL by CD8+ autologous T lymphocytes.
Bund D; Mayr C; Kofler DM; Hallek M; Wendtner CM
Exp Hematol; 2007 Jun; 35(6):920-30. PubMed ID: 17533046
[TBL] [Abstract][Full Text] [Related]
36. Autologous cytomegalovirus-specific T cells as effector cells in immunotherapy of B cell chronic lymphocytic leukaemia.
Kater AP; Remmerswaal EB; Nolte MA; Eldering E; van Oers MH; van Lier RA
Br J Haematol; 2004 Aug; 126(4):512-6. PubMed ID: 15287944
[TBL] [Abstract][Full Text] [Related]
37. Chronic lymphocytic leukaemia cells become both activated and immunosuppressive following interaction with CD3 and CD28 stimulated PBMC.
Hock BD; Macpherson SA; Fernyhough LJ; McKenzie JL
Leuk Res; 2014 Oct; 38(10):1217-23. PubMed ID: 24976339
[TBL] [Abstract][Full Text] [Related]
38. Biology of the neoplastic lymphocyte in B-CLL.
Dighiero G
Baillieres Clin Haematol; 1993 Dec; 6(4):807-20. PubMed ID: 8038491
[TBL] [Abstract][Full Text] [Related]
39. The expression of NK cell inhibitory receptors on cytotoxic T cells in B-cell chronic lymphocytic leukaemia (B-CLL).
Junevik K; Werlenius O; Hasselblom S; Jacobsson S; Nilsson-Ehle H; Andersson PO
Ann Hematol; 2007 Feb; 86(2):89-94. PubMed ID: 17043777
[TBL] [Abstract][Full Text] [Related]
40. Immunophenotypic and DNA genotypic analysis of T-cell and NK-cell subpopulations in patients with B-cell chronic lymphocytic leukaemia (B-CLL).
Frolova EA; Richards SJ; Jones RA; Rawstron A; Master PS; Teasdale J; Short M; Jack AS; Scott CS
Leuk Lymphoma; 1995 Jan; 16(3-4):307-18. PubMed ID: 7719238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]